Paxton-Digital Puts Prognosis at the Center of Paxton Scout: IP, Market and Clinical Outlooks
Paxton Scout puts prognosis at its center — an IP and market outlook and a clinical outlook — plus a free patent term and exclusivity estimator.
NORTH MYRTLE BEACH, S.C. — October 9, 2026 — Paxton-Digital today announced that prognosis is now the central focus of Paxton Scout, its flagship intelligence workspace — bringing research and product teams two outlooks in one place: an IP and market outlook and a clinical outlook for the technologies they are developing or evaluating.
Scout is the command center for research, intelligence and strategic execution — evidence queues, opportunity and competitive monitoring, AI-assisted analysis, campaign dashboards and research drafting. Prognosis brings those modules together to answer the two questions every health-technology team eventually faces: How long can we protect this, and how likely is it to work?
Two outlooks, one workspace
- IP & market outlook — patent landscape and term, freedom-to-operate signals, competitive filings and the window of protected sales, drawn from Scout’s Intellectual Property Protection module with its focus on drug delivery, nano-encapsulation and healthcare AI.
- Clinical outlook — the evidence base, study status and open questions for a mechanism or delivery approach, organized in Scout’s Evidence & Research queues and summarized by its AI-assisted analysis layer with sources attached.
Prognosis is an analytical aid for professionals. It does not provide medical advice, legal opinions or guarantees of outcome.
From capsule to market
Many delivery programs start with the capsule itself. Teams evaluating gelatin and collagen-based capsule materials can review supplier options from Darling Ingredients and its Rousselot gelatin brand. (Darling Ingredients is an independent company with no affiliation to Paxton-Digital.)
And for facilities that hold sensitive research, secure door entry is part of protecting IP. Learn more about access control at Paxton-Access.
Try a first-pass IP outlook
The fastest way to understand a market window is to know when protection ends. Estimate it below:
Patent Term & Exclusivity Estimator
A first-pass view of how long a U.S. utility patent can protect a product — the starting point of any IP and market prognosis.
Simplified estimate: 20 years from the earliest U.S. non-provisional filing date, plus any patent term adjustment. Excludes terminal disclaimers, maintenance-fee lapses, patent term extension and other regulatory exclusivities. Not legal advice — consult a registered patent attorney.
Get digital access
Scout is included with an eligible paid Paxton-Digital subscription, billed monthly or annually. Monthly digital access includes the Scout workspace, core intelligence tools and the AI analysis layer; annual digital access adds expanded access, annual-only modules, advanced IP monitoring, priority support and early access to new releases. Sign in at login.paxton-digital.com or scout.paxton-digital.com, and see plans at Paxton-Digital.com.
About Paxton-Digital
Paxton-Digital is an operating technology, intelligence and digital-infrastructure company within the Kingswell Strategic Ventures, LLC portfolio, based in North Myrtle Beach, South Carolina. It builds software and systems that turn ideas into protected, scalable operations. Contact sales@paxton-digital.com.